Epithelial to mesenchymal transition as a portal to stem cell characters embedded in gene networks

BioEssays

Volumn 35, Issue 3, 2013, Pages 191-200

  Asli, Naisana S ^a,b   Harvey, Richard P ^a,b,c  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Epicardium; Epithelial to mesenchymal transition; Heart regeneration; Reprogramming; Stem cells

Indexed keywords

UVOMORULIN;

ARTICLE; CELL DIFFERENTIATION; CELL JUNCTION; CELL REGENERATION; CELL TRANSFORMATION; EPICARDIUM; EPITHELIUM CELL; MESENCHYME CELL; STEM CELL;

ADHERENS JUNCTIONS; ANIMALS; CELL LINEAGE; EPITHELIAL-MESENCHYMAL TRANSITION; GENE REGULATORY NETWORKS; HUMANS; NEOPLASMS; STEM CELLS;

EID: 84873536071     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200089     Document Type: Article

References (107)

1. Hay ED. 2005. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-20.
2. Polyak K, Weinberg RA. 2009. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-73.
3. Yao D, Dai C, Peng S. 2011. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 9: 1608-20.
4. Mani SA, Guo W, Liao MJ, Eaton EN, et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-15.
5. Guo W, Keckesova Z, Donaher JL, Shibue T, et al. 2012. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 148: 1015-28.
6. Peinado H, Olmeda D, Cano A. 2007. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-28.
7. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-90.
8. Nishimura T, Honda H, Takeichi M. 2012. Planar cell polarity links axes of spatial dynamics in neural tube closure. Cell 149: 1084-97.
9. Nieto MA. 2011. The ins and outs of the epithelial to mesenchymal transition in health and disease. Ann Rev Cell Dev Biol 27: 347-76.
10. Rorth P. 2009. Collective cell migration. Ann Rev Cell Dev Biol 25: 407-29.
11. Wang Y-C, Zhan Z, Kaschube M, Wieschaus EF. 2012. Differential positioning of adherens junctions is associated with initation of epithelial folding. Nature 484: 390-3.
12. Zavadil J, Bitzer M, Liang D, Yang YC, et al. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 98: 6686-91.
13. Baum B, Settleman J, Quinlan MP. 2008. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294-308.
14. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-8.
15. Na YR, Seok SH, Kim DJ, Han JH, et al. 2009. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100: 2218-25.
16. Hollier BG, Evans K, Mani SA. 2009. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J Mammary Gland Biol 14: 29-43.
17. Wang Y, Zhou BP. 2011. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin J Cancer 30: 603-11.
18. Vincent T, Neve EP, Johnson JR, Kukalev A, et al. 2009. A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol 11: 943-50.
19. Yook JI, Li XY, Ota I, Fearon ER, et al. 2005. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 280: 11740-8.
20. Timmerman LA, Grego-Bessa J, Raya A, Bertran E, et al. 2004. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Gene Dev 18: 99-115.
21. Leong KG, Niessen K, Kulic I, Raouf A, et al. 2007. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204: 2935-48.
22. Min C, Eddy SF, Sherr DH, Sonenshein GE. 2008. NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-44.
23. Wu CY, Tsai YP, Wu MZ, Teng SC, et al. 2012. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet 28: 454-63.
24. Yang J, Weinberg RA. 2008. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-29.
25. Bullock MD, Sayan AE, Packham GK, Mirnezami AH. 2012. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell 104: 3-12.
26. Ma L. 2010. Role of miR-10b in breast cancer metastasis. Breast Cancer Res 12: 210.
27. Khew-Goodall Y, Goodall GJ. 2010. Myc-modulated miR-9 makes more metastases. Nat Cell Biol 12: 209-11.
28. Chang CJ, Chao CH, Xia W, Yang JY, et al. 2011. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat Cell Biol 13: 317-23.
29. Ip YT, Gridley T. 2002. Cell movements during gastrulation: snail dependent and independent pathways. Curr Opin Genet Dev 12: 423-9.
30. Grau Y, Carteret C, Simpson P. 1984. Mutations and chromosomal rearrangements affecting the expression of snail, a gene involved in embryonic patterning in Drosophila melanogaster. Genetics 108: 347-60.
31. Simpson P. 1983. Maternal-zygotic gene interactions during formation of the dorsoventral pattern in drosophila embryos. Genetics 105: 615-32.
32. Grobhans J, Wieschaus E. 2000. A genetic link between morphogenesis and cell division during formation of the ventral furrow in drosophila. Cell 101: 523-31.
33. Nieto MA. 2002. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3: 155-66.
34. Nieto MA, Sargent MG, Wilkinson DG, Cooke J. 1994. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264: 835-9.
35. Carver EA, Jiang R, Lan Y, Oram KF, et al. 2001. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 21: 8184-8.
36. Yang DC, Tsai CC, Liao YF, Fu HC, et al. 2011. Twist controls skeletal development and dorsoventral patterning by regulating runx2 in zebrafish. PloS ONE 6: e27324.
37. Martinez-Estrada OM, Lettice LA, Essafi A, Guadix JA, et al. 2010. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet 42: 89-93.
38. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-54.
39. Fidler IJ, Poste G. 2008. The "seed and soil" hypothesis revisited. Lancet Oncol 9: 808.
40. Hsieh TH, Tsai CF, Hsu CY, Kuo PL, et al. 2012. Phthalates stimulate the epithelial to mesenchymal transition through an HDAC-6-dependent mechanism in human breast epithelial stem cells. Toxicol Sci 128: 365-76.
41. Vendrell JA, Thollet A, Nguyen NT, Ghayad SE, et al. 2012. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invastion. Cancer Res 72: 3593-606.
42. Cakouros D, Isenmann S, Cooper L, Zannettino A, et al. 2012. Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells. Mol Cell Biol 32: 1433-1.
43. Dong C, Wu Y, Wang Y, Kang T, et al. 2012. Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene, in press, DOI: 10.1038/onc.2012.169.
44. Perez-Mancera PA, Perez-Carlo M, Gonzalez-Herrero I, Florez T, et al. 2005. Cancer development induced by graded expression of snail in mice. Hum Mol Genet 14: 3449-61.
45. Thallainadesan G, Chitilian JM, Isovic M, Ablack JG, et al. 2012. TGF-b-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 46: 1-14.
46. Song LB, Li J, Liao WT, Feng Y, et al. 2009. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-36.
47. Lin T, Ponn A, Hu X, Law BK, et al. 2010. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 29: 4896-904.
48. Molchadsky A, Rivlin N, Brosh R, Rotter V, et al. 2010. p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis 31: 1501-8.
49. Cheng GZ, Chan J, Wang Q, Zhang W, et al. 2007. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 1979-87.
50. Vega S, Morales AV, Ocana OH, Valdes F, et al. 2004. Snail blocks the cell cycle and confers resistance to cell death. Gen Dev 18: 1131-43.
51. Haslehurst AM, Koti M, Dharsee M, Nuin P, et al. 2012. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 12: 91.
52. Inoue A, Seidel MG, Wu W, Kamizono S, et al. 2002. Slug, a highly conserved zinc finger transcriptional repressor, protects hematopoietic progenitor cells from radiation-induced apoptosis in vivo. Cancer Cell 2: 279-88.
53. Wu WS, Heinrichs S, Xu D, Garrison SP, et al. 2005. Slug antagonises p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell Stem Cell 123: 641-53.
54. Rinon A, Molchadsky A, Nathan E, Yovel G, et al. 2011. p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes. Development 138: 1827-38.
55. Goossens S, Haigh JJ, 2012. The role of EMT modulators in hematopoiesis and leukemic transformation. In Lawrie C, ed; Hematology - Science and Practice. Intech. p. 101-120 online open access publisher.
56. Goossens S, Janzen V, Bartunkova S, Yokomizo T, et al. 2011 The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization. Blood 117: 5620-30.
57. Perez-Losada J, Sanchez-Martin M, Rodriguez-Garcia A, Sanchez ML, et al. 2002. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 100: 1274-86.
58. Isenmann S, Arthur A, Zannettino AC, Turner JL, et al. 2009. TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27: 2457-68.
59. Cakouros D, Raices RM, Gronthos S, Glackin CA. 2010. Twist-ing cell fate: mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis. J Cell Biochem 110: 1288-98.
60. Singh A, Settleman J. 2010. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-51.
61. Woodward WA, Chen MS, Behbod F, Rosen JM. 2005. On mammary stem cells. J Cell Sci 118: 3585-94.
62. Moumen M, Chiche A, Cagnet S, Petit V, et al. 2011. The mammary myoepithelial cell. Int J Dev Biol 55: 763-71.
63. Shipitsin M, Campbell LL, Argani P, Weremowicz S, et al. 2007. Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-73.
64. Petersen OW, Polyak K. 2010. Stem cells in the human breast. Cold Spring Harb Perspect Biol 2: a003160.
65. Lindeman GJ, Visvader JE. 2010. Insights into the cell of origin in breast cancer and breast cancer stem cells. Asia Pac J Clin Oncol 6: 89-97.
66. Lim E, Vaillant F, Wu D, Forrest NC, et al. 2009. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-13.
67. Molyneux G, Geyer FC, Magnay FA, McCarthy A, et al. 2010. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 7: 403-17.
68. Vesuna F, Lisok A, Kimble B, Raman V. 2009. Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11: 1318-28.
69. Battula VL, Evans KW, Hollier BG, Shi Y, et al. 2010. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem cells 28: 1435-45.
70. Morel AP, Lievre M, Thomas C, Hinkal G, et al. 2008. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS ONE 3: e2888.
71. Hwang WL, Yang MH, Tsai ML, Lan HY, et al. 2011. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology 141: 279-91, 291.e1-5.
72. Takahashi K, Tanabe K, Ohnuki M, Narita M, et al. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-72.
73. Enver T, Pera M, Peterson C, Andrews PW. 2009. Stem cell sates, fates, and the rule of attraction. Cell Stem Cell 4: 387-97.
74. Huang S. 2009. Reprogramming cell fates: reconciling rarity with robustness. BioEssays 31: 546-60.
75. Li R, Liang J, Ni S, Zhou T, et al. 2010. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7: 51-63.
76. Redmer T, Diecke S, Grigoryan T, Quiroga-Negreira A, et al. 2011. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming. EMBO Rep 12: 720-6.
77. Chen T, Yuan D, Wei B, Jiang J, et al. 2010. E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 28: 1315-25.
78. Chen J, Liu J, Yang J, Chen Y, et al. 2011. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res 21: 205-12.
79. Liao B, Bao X, Liu L, Feng S, et al. 2011. MicroRNA cluster 302-367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transition. J Biol Chem 286: 17359-64.
80. Samavarchi-Tehrani P, Golipour A, David L, Sung HK, et al. 2010. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7: 64-77.
81. Bolli R, Chugh AR, D'Amario D, Loughran JH, et al. 2011. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378: 1847-57.
82. Makkar RR, Smith RR, Cheng K, Malliaras K, et al. 2012. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 397: 895-904.
83. Xu H, Yi BA, Wu H, Bock C, et al. 2012. Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Res 22: 142-54.
84. Song K, Nam Y-J, Luo X, Qi X, et al. 2012. Heart repair by reprograming non-myocytes with cardiac transcription factors. Nature 485: 599-604.
85. Qian L, Huang Y, Spencer CI, Foley A, et al. 2012. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485: 593-8.
86. Kovacic JC, Mercader N, Torres M, Boehm M, et al. 2012. Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 125: 1795-808.
87. von Gise A, Pu WT. 2012. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res 110: 1628-45.
88. Gittenberger-de-Groot AC, Winter EM, Bartelings MM, Goumans MJ, et al. 2012. The arterial and cardiac epicardium in development, disease and repair. Differentiation 84: 41-53.
89. Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, et al. 2011. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9: 527-40.
90. Kikuchi K, Holdway JE, Werdich AA, Anderson RM, et al. 2010. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature 464: 601-5.
91. Lepilina A, Coon AN, Kikuchi K, Holdway JE, et al. 2006. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127: 607-19.
92. Kikuchi K, Holdway JE, Major RJ, Blum N, et al. 2011. Retinoic acid production by endocardium and epicardium is an injury response essential for zebrafish heart regeneration. Dev Cell 20: 397-404.
93. Kim J, Wu Q, Zhang Y, Wiens KM, et al. 2010. PDGF signaling is required for epicardial function and blood vessel formation in regenerating zebrafish hearts. Proc Natl Acad Sci USA 107: 17206-10.
94. Bax NA, van Oorschot AA, Maas S, Braun J, et al. 2011. In vitro epithelial-to-mesenchymal transformation in human adult epicardial cells is regulated by TGFbeta-signaling and WT1. Basic Res Cardiol 106: 829-47.
95. Di Meglio F, Castaldo C, Nurzynska D, Romano V, et al. 2010. Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart. J Mol Cell Cardiol 49: 719-27.
96. Winter EM, Van Oorschot AA, Hogers B, van der Graaf LM, et al. 2009. A new direction for cardiac regeneration therapy: application of synergistially acting epicardium-derived cells and cardiomyocyte precursor cells. Circ Heart Fail 2: 643-53.
97. Zhou B, Honor LB, He H, Ma Q, et al. 2011. Adult mouse epicadrium modulates myodardial injury by secreting paracrine factors. J Clin Invest 121: 1894-904.
98. Gittenberger-de Groot AC, Winter EM, Poelmann RE. 2010. Epicardium-derived cells (EPDCs) in development, cardiac disease and repair of ischemia. J Cell Mol Med 14: 1056-60.
99. Limana F, Germani A, Zacheo A, Kajstura J, et al. 2005. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res 97: e73-83.
100. Smart N, Risebro CA, Melville AA, Moses K, et al. 2007. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445: 177-82.
101. Bock-Marquette I, Shrivastava S, Pipes GCT, Thatcher JE, et al. 2010. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo. J Mol Cell Cardiol 46: 728-38.
102. Smart N, Bollini S, Dube KN, Vieira JM, et al. 2011. De novo cardiomyocytes from within the activated adult heart after injury. Nature 474: 640-4.
103. Qian L, Huang Y, Spencer CI, Foley A, et al. 2012. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485: 593-8.
104. Ring KL, Tong LM, Balestra ME, Javier R, et al. 2012. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 11: 100-9.
105. Szabo E, Rampalli S, Risueno RM, Schnerch A, et al. 2010. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468: 521-6.
106. Holmberg J, Perlmann T. 2012. Maintaining differentiated cellular identity. Nat Rev Genet 13: 429-39.
107. Kikuchi K, Gupta V, Wang J, Holdway JE, et al. 2011. tcf21+ epicardial cells adopt non-myocardial fates during zebrafish heart development and regeneration. Development 138: 2895-902.